A comprehensive view of Initial Public Offering (IPO). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Executive Perspective: Cava's IPO last June was 'not a destination, it was just another step in our journey,' says CFO Tricia Tolivar, adding that going public required extensive preparation over the course of about 18-24 months
Published:
March 28, 2024
by CFO Dive
|
Galderma prices IPO at CHF 53/share and will start trading on the SIX Swiss Exchange tomorrow
Published:
March 21, 2024
by Business Wire
|
Indorama Ventures to separate, list its surfactants business--the downstream part of its Integrated Oxides and Derivatives business--via IPO; it will be named Indovinya and listed in US, while upstream part will transfer to Combined PET segment: ICIS
Published:
March 15, 2024
by ICIS Chemical Business (CBNB Abstracts)
|
Indorama Ventures intends to separate and list its packaging unit through an IPO; business generates PET preforms bottles and closures, has grown almost 11%-12%/year in past three to five years, would be listed in Asia: ICIS
Published:
March 15, 2024
by ICIS Chemical Business (CBNB Abstracts)
|
Galderma Launches IPO on the SIX Swiss Exchange and Sets Price Range
Published:
March 13, 2024
by Business Wire
|
Ask us about our Health Care Sector market view